// App-Quantinova.ai

PO0287 : Treatment Pathways of Non-Dialysis-Dependent CKD Patients with Anemia: A Report from the DISCOVER CKD Retrospective Cohort

Researchers

Presenter

  • Wittbrodt EricT

Principal Investigators

  • Carrero JuanJesus

  • James Glen

  • Fishbane Steven

  • Kumar SupriyaR

  • Pecoits-Filho Roberto

  • Garcia Sanchez Juan Jose

  • Pollock CarolA

  • Sloand JamesA

  • Hedman Katarina

  • Wheeler DavidC

Medical Centers

  • AstraZeneca Gaithersburg Maryland United States

  • Karolinska Institutet, Stockholm, Stockholms Lan, Sweden

  • AstraZeneca UK Ltd Cambridge Cambridgeshire United Kingdom

  • Northwell Health, Manhasset, New York, United States

  • Pontificia Universidade Catolica do Parana (PUC-PR), Curitiba, Brazil

  • University of Sydney, Sydney, New South Wales, Australia

  • AstraZeneca, Gothenburg, Sweden

  • Kings College London, London, United Kingdom

Locations

  • United States

  • Sweden

  • United Kingdom

  • Brazil

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Non-dialysis-dependent chronic kidney disease

  • Anemia

Biomarkers

  • Epithelial Cell Adhesion Molecule

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved